SMAD3 and neoplasm: Since hetero-oligomerization is needed to bind target-specific transcriptional complexes in the nucleus [38], two different types of phospho-Smad3 transmit different signals, which is consistent with the ability of Smad4 to act as both a tumor repressor and a tumor activator [39].